Hemostemix Inc.
HMTXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $10 | $5 | $12 | $9 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $5 | $4 | $4 | $1 |
| Enterprise Value | $14 | $10 | $16 | $10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$3 | -$5 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.028 | -0.03 | -0.075 | -0.11 |
| % Growth | 9.2% | 59.5% | 32% | – |
| Operating Cash Flow | -$2 | -$1 | -$6 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | -$6 | -$3 |